For the Inventor, By the Inventor

Enter assignee name

Mect Corporation

USPTO Granted Patents = 45

Forward Citations = 309

Loading Chart...

Loading Chart...

73 inventors (with patents filed for the assignee):

Tomoya Ogawa (22 out of 30 patents)

Masayoshi Ito (22 out of 30 patents)

Yoshiyasu Shitori (21 out of 26 patents)

4. Mamoru Sugimoto (17 out of 20 patents)

5. Masaaki Numata (13 out of 13 patents)

6. Shoji Yoshimura (11 out of 14 patents)

7. Takayuki Ishii (6 out of 31 patents)

8. Kenkichi Tomita (6 out of 6 patents)

9. Makoto Tanaka (6 out of 9 patents)

10. Yoshitaka Nagai (5 out of 10 patents)

11. Haruo Ogura (5 out of 8 patents)

12. Kimio Furuhata (5 out of 6 patents)

13. Shohei Shibayama (4 out of 6 patents)

14. Isao Suda (4 out of 4 patents)

15. Masatoshi Yamato (4 out of 6 patents)

Core Competencies:

Immune Modulation

Anti-Inflammatory Agents

Monoclonal Antibodies

Sialic Acid Derivatives

Glycolipids

Neuropathy Remedies

Carcinostatic Compositions

Sialosyl Compounds

Quinoline Derivatives

Chemotaxis Inhibition

Renal Disease Treatment

Arteriosclerosis Treatment

45 patents: Sort by Forward Citations

1. 5763420 - Method for modulating the immune system (1998-06-09),

2. 5763413 - Lewis-associated compound, process for producing the same, and (1998-06-09),

3. 5668115 - Methods for inhibiting the chemotaxis of neutrophils (1997-09-16),

4. 5611445 - Lid for container (1997-03-18),

5. 5516764 - Anti-inflammatory agent (1996-05-14),

6. 5470962 - Oligosialyl-1,2-dialkyl-sn-glycerols and synthetic intermediates for (1995-11-28),

7. 5393742 - Preparation for treating renal disease (1995-02-28),

8. 5264567 - GM.sub.3 analogous compound (1993-11-23),

9. 5231177 - Sodium N-acetylneuraminate trihydrate (1993-07-27),

10. 5217961 - Condensed quinoline system N-glycosides (1993-06-08),

11. 5177062 - Method for treating immune complex diseases with n-acetylneuraminic acid (1993-01-05),

12. 5173420 - Monoclonal antibody recognizing un-natural ganglioside GD3 (1992-12-22),

13. 5158886 - Monoclonal antibodies specific for free N-acetylfuraminic acid and (1992-10-27),

14. 5142028 - Monoclonal antibodies capable of recognizing gangliosides GQ.sub.1b and (1992-08-25),

15. 5141864 - Monoclonal antibody recognizing alpha 2.fwdarw.3 bonds (1992-08-25),

Mect Corporation is a global technology company specializing in providing advanced solutions for industries such as manufacturing, automation, and robotics. With a strong focus on innovation, Mect Corporation develops cutting-edge products and systems that optimize efficiency, productivity, and reliability for their clients. Their diverse range of offerings includes industrial robots, custom manufacturing equipment, software solutions, and consulting services. Mect Corporation is committed to delivering top-quality solutions tailored to meet the unique needs of each client, making them a trusted partner in the industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

45 Patents

#743 in Tokyo

#1,790 in Japan

#14,979 in the World

Mect Corporation

Forward Citations = 309

73 inventors:

Tomoya Ogawa (22 out of 30 patents)

Masayoshi Ito (22 out of 30 patents)

Yoshiyasu Shitori (21 out of 26 patents)

4. Mamoru Sugimoto (17 out of 20 patents)

5. Masaaki Numata (13 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…